Anaphylatoxins C5a and C3a induce nuclear factor κB activation in human peripheral blood monocytes

Biochimica et Biophysica Acta - Gene Structure and Expression

Volumn 1443, Issue 1-2, 1998, Pages 90-98

  Pan, Zhixing K ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Anaphylatoxin; G protein coupled receptor; Monocyte; Transcription factor

Indexed keywords

ANAPHYLATOXIN; CHOLERA TOXIN; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; GUANINE NUCLEOTIDE BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PERTUSSIS TOXIN;

ARTICLE; BINDING AFFINITY; DNA PROTEIN COMPLEX; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL;

BACTERIAL TOXINS; BENZOQUINONES; BLOTTING, WESTERN; CELL NUCLEUS; COMPLEMENT C3A; COMPLEMENT C5A; DNA-BINDING PROTEINS; ENZYME INHIBITORS; GENISTEIN; HUMANS; I-KAPPA B PROTEINS; LACTAMS, MACROCYCLIC; MONOCYTES; NF-KAPPA B; PROTEIN-TYROSINE KINASES; QUINONES;

EID: 0032570062     PISSN: 01674781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4781(98)00198-5     Document Type: Article

References (46)

1. Cochrane C.G., Muller-Eberhard H.J. The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement. J. Exp. Med. 127:1968;368-371.
2. D. Bitter-Suermann, The anaphylatoxins, in: K. Rother, G.O. Till (Eds.), The Complement System, Springer-Verlag, Berlin, 1988, pp. 367-395.
3. Hugli T.E., Muller-Eberhard H.J. Anaphylatoxins C3a and C5a. Adv. Immunol. 26:1978;26-53.
4. I.M. Goldstein, Complement: biologically active products, in: J.I. Gallin, I.M. Goldstein, R. Snyderman (Eds.), Inflammation: Basic Principles and Clinical Correlates, Raven Press, New York, 1988, pp. 55-74.
5. Gerard C., Gerard N.P. C5A anaphylatoxin and its seven transmembrane-segment receptor. Annu. Rev. Immunol. 12:1994;775-808.
6. Daffern P.J., Pfeifer P.H., Ember J.A., Hugli T.E. C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation. J. Exp. Med. 181:1995;2119-2127.
7. Hartmann K., Henz B.M., Kruger-Krasagakes S., Kohl J., Burger R., Guhl S., Haase I., Lippert U., Zuberbier T. C3a and C5a stimulate chemotaxis of human mast cells. Blood. 89:1997;2863-2870.
8. Klos A., Bank S., Gietz C., Bautsch W., Kohl J., Burg M., Kretzschmar T. C3a receptor on dibutyryl-cAMP-differentiated U937 cells and human neutrophils: the human C3a receptor characterized by functional responses and 125-I-C3a binding. Biochemistry. 31:1992;11274-11282.
9. Norgauer J., Dobos G., Kownatzki E., Dahinden C., Burger R., Kupper R., Gierschik P. Complement fragment C3a stimulates Ca2+ influx in neutrophils via a pertussis-toxin-sensitive G protein. Eur. J. Biochem. 217:1993;289-294.
10. Goodman M.G., Chenoweth D.E., Weigle W.O. Induction of interleukin 1 secretion and enhancement of humoral immunity by binding of human C5a to macrophage surface C5a receptors. J. Exp. Med. 1156:1982;912-917.
11. Okusawa S., Dinarello C.A., Yancy K.B., Endres S., Lawley T.J., Frank M.M., Burke J.F., Gelfand J.A. C5a induction of human interleukin 1. Synergistic effect with endotoxin or interferon gamma. J. Immunol. 8:1987;2635-2640.
12. Okusawa S., Yancy K.B., van der Meer J.W.M., Endres S., Lonnemann G., Hefterr K., Frank M.M., Burke J.F., Dinarello C.A., Gelfand J.A. C5a stimulates secretion of tumor necrosis factor from human mononuclear cells in vitro. J. Exp. Med. 168:1988;443-448.
13. Schindler R., Gelfand J.A., Dinarello C.A. Recombinant C5a stimulates transcription rather than translation of interleukin-1 (IL-1) and tumor necrosis factor: translational signal provided by lipopolysaccharide or IL-1 itself. Blood. 76:1990;1631-1638.
14. Ember J.A., Sanderson S.D., Hugli T.E., Morgan E.L. Induction of interleukin-8 synthesis from monocytes by human C5a anaphylatoxin. Am. J. Pathol. 144:1994;393-403.
15. Haeffner-Cavaillon N., Cavaillon J.-M., Laude M., Kazatchkine M.D. C3a (C3a des-Arg) induces production and release of interleukin-1 by cultured human monocytes. J. Immunol. 139:1987;794-799.
16. Takabayashi T., Vannier E., Clark B.D., Margolis N.H., Dinarello C.A., Burke J.F., Gelfand J.A. A new biologic role for C3a and C3a desArg: regulation of TNF-alpha and IL-1 beta synthesis. J. Immunol. 156:1996;3455-3460.
17. Sen R., Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell. 46:1986;705-716.
18. Baeuerle P.A., Baltimore D. IκB: a specific inhibitor of the NF-κB transcription factor. Science. 242:1988;540-546.
19. Haskill S., Beg A.A., Tompkins S.M., Morris J.S., Yurochko A.D., Sampson-Johannes A., Mondal K., Ralph P., Baldwin A.S. Characterization of an immediate-early gene induced in adherent monocytes that encodes I kappa B-like activity. Cell. 65:1991;1281-1289.
20. Henkel T., Machleidt T., Alkalay I., Kranke M., Ben-Neriah Y., Baeuerle P.A. Rapid proteolysis of IκB-alpha is necessary for activation of transcription factor NF-κB. Nature. 365:1993;182-185.
21. Regnier C.H., Yeong Song H., Gao X., Goeddel D.V., Cao Z., Rothe M. Identification and characterization of an IκB kinase. Cell. 90:1997;373-383.
22. DiDonato J.A., Hayakawa M., Rothwarf D.M., Zandi E., Karin M. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature. 388:1997;548-554.
23. Zandi E., Rothwarf D.M., Delhase M., hayakawa M., Karin M. The IκB kinase complex (IKK) contains two kinase subunits, IKK-alpha and IKK-beta, necessary for IκB phosphorylation and NF-κB activation. Cell. 91:1997;243-252.
24. Mercurio F., Zhu H., Murray B.W., Shevchenko A., Bennett B.L., Li J.W., Young D.B., Barbosa M., Mann M., Manning M., Rao A. IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation. Science. 278:1997;860-866.
25. Woronicz J.D., Gao X., Cao Z., Rothe M., Goeddel D.V. IκB kinase-beta: NF-κB activation and complex formation with IκB kinase-alpha and NIK. Science. 278:1997;866-869.
26. Baeuerle P.A., Henkel T. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 32:1994;141-179.
27. Pan Z.K., Kravchenko V.V., Ye R.D. Platelet-activating factor stimulates transcription of the heparin-binding epidermal growth factor-like growth factor in monocyte. Correlation with an increased kappa B binding activity. J. Biol. Chem. 270:1995;7787-7790.
28. Pan Z.K., Zuraw B.L., Lung C.C., Prossnitz E.R., Browning D.D., Ye R.D. Bradykinin stimulates NF-κB activation and IL-1-beta gene expression in cultured human fibroblasts. J. Clin. Invest. 98:1996;2042-2049.
29. Brach M.A., de Vos S., Arnold C., Gruss H.-J., Mertelsmann R., Herrmann F. Leukotriene B4 transcriptionally activates interleukin-6 expression involving NF-κB and NF-IL6. Eur. J. Immunol. 22:1992;2705-2711.
30. Mari B., Imbert V., Belhacene N., Far D.F., Peyron J.F., Pouyssegur J., Van Obberghen Schilling E., Rossi B., Auberger P. Thrombin and thrombin receptor agonist peptide induce early events of T cell activation and synergize with TCR cross-linking for CD69 expression and interleukin 2 production. J. Biol. Chem. 269:1994;8517-8523.
31. Sun S.C., Ganchi P.A., Ballard D.W., Greene W.C. NF-κB controls expression of inhibitor IκB-alpha: evidence for an inducible autoregulatory pathway. Science. 259:1993;1912-1915.
32. Dignam J.D., Lebovitz R.M., Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1983;1475-1489.
33. Brown K., Park S., Kanno T., Franzoso G., Siebenlist U. Mutual regulation of the transcriptional activator NF-κB and its inhibitor IκB-alpha. Proc. Natl. Acad. Sci. USA. 90:1993;2532-2536.
34. Scott M.L., Fujita T., Liou H.-C., Nolan G.P., Baltimore D. The p65 subunit of NF-κB regulates IκB by two distinct mechanisms. Genes Dev. 7:1993;1266-1276.
35. Rice N.R., Ernst M.K. In vivo control of NF-kappa B activation by I kappa B alpha. EMBO J. 12:1993;4685-4695.
36. Chiao P.J., Miyamoto S., Verma I.M. Autoregulation of IκB-alpha activity. Proc. Natl. Acad. Sci. USA. 91:1994;28-32.
37. Liou H.C., Baltimore D. Regulation of the NF-κB/rel transcription factor and IκB inhibitor system. Curr. Biol. 5:1993;477-487.
38. Gerard N.P., Gerard C. The chemotactic receptor for human C5a anaphylatoxin. Nature. 349:1991;614-617.
39. Boulay F., Mery L., Tardif M., Brouchon L., Vignais P. Expression cloning of a receptor for C5a anaphylatoxin on differentiated HL-60 cells. Biochemistry. 30:1991;2993-2999.
40. Crass T., Raffetseder U., Martin U., Grove M., Klos A., Kohl J., Bautsch W. Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U-937 cells. Eur. J. Immunol. 26:1996;1944-1950.
41. Ames R.S., Li Y., Sarau H.M., Nuthulaganti P., Foley J.J., Ellis C., Zeng Z., Su K., Jurewicz A.J., Hertzberg R.P., Bergsma D.J., Kumar C. Molecular cloning and characterization of the human anaphylatoxin C3a receptor. J. Biol. Chem. 271:1996;20231-20234.
42. Roglic A., Prossnitz E.R., Cavanagh S.L., Pan Z.K., Zou A., Ye R.D. cDNA cloning of a novel G protein-coupled receptor with a large extracellular loop structure. Biochim. Biophys. Acta. 1305:1996;39-43.
43. Monk P.N., Banks P. Evidence for the involvement of multiple signalling pathways in C5a-induced actin polymerization and nucleation in human monocyte-like cells. J. Mol. Endocrinol. 6:1991;241-247.
44. Nilsson G., Johnell M., Hammer C.H., Tiffany H.L., Nilsson K., Metcalfe D.D., Siegbahn A., Murphy P.M. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway. J. Immunol. 157:1996;1693-1698.
45. Dobos G.J., Norgauer J., Eberle M., Schollmeyer P.J., Traynor-Kaplan A.E. C5a reduces formyl peptide-induced actin polymerization and phosphatidylinositol (3,4,5) trisphosphate formation, but not phosphatidylinositol (4,5) bisphosphate hydrolysis and superoxide production, in human neutrophils. J. Immunol. 149:1992;609-614.
46. Lenardo M.J., Baltimore D. NF-κB: a pleiotropic mediator of inducible and tissue-specific gene control. Cell. 58:1989;227-229.